MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
Acutus Medical Operating Income 2011-2026 | AFIB
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.7 M | 41 M | -112 M | -91.3 M | -72.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 41 M | -112 M | -49.3 M |
Quarterly Operating Income Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 489 K | 301 K | -575 K | - | -1.69 M | -3.06 M | -5.27 M | - | -20.5 M | 14.9 M | -38.6 M | - | -27.1 M | -27.3 M | -27.8 M | - | -26.3 M | -19.5 M | -17.6 M | - | -31.2 M | -13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.9 M | -38.6 M | -14.4 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
608 M | $ 191.66 | 0.84 % | $ 14.4 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.67 | 0.08 % | $ 1.71 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.42 | -2.01 % | $ 128 M |  France |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 60.99 | -5.03 % | $ 90.3 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.65 | -2.26 % | $ 40.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.16 | -5.34 % | $ 316 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 25.4 | -2.53 % | $ 215 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.05 | -0.94 % | $ 17.8 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 96.82 | 1.65 % | $ 13.1 B | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 5.49 | 0.73 % | $ 1.16 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.12 | - | $ 1.29 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 10.88 | 0.18 % | $ 390 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 65.81 | -1.95 % | $ 3.59 B |  Britain |
 |
Inogen
INGN
|
-30.2 M | $ 6.95 | 1.91 % | $ 185 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 56.97 | -1.08 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 39.68 | 1.54 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 89.32 | -0.98 % | $ 3.1 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.65 | -0.6 % | $ 391 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.8 | - | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 81.44 | 0.56 % | $ 47.6 B | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.55 | -6.41 % | $ 66.4 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.9 | 4.73 % | $ 37.7 M | USA |
 |
Smith & Nephew plc
SNN
|
593 M | $ 34.21 | -0.44 % | $ 23.8 B | Britain |